Convergent IGHV3-53/3-66 antibodies elicited by Omicron BA.1 infection broadly neutralize emerging SARS-CoV-2 variants
Naveenchandra Suryadevara, Seth J. Zost, John M. Powers, Bernadeta Dadonaite, Pavlo Gilchuk, Elad Binshtein, Suzanne M. Scheaffer, Sarah R. Leist, Luke Myers, Silvia Ravera, Lily E. Adams, Laura S. Handal, Shruthi Kannan, Edgar Davidson, Benjamin Doranz, , James E. Crowe
The paper investigates how IGHV3-53/3-66 antibodies from Omicron BA.1 infection neutralize emerging SARS-CoV-2 variants through structural and mutational analysis.
bioRxiv · Aug 20, 2026 · PreprintImmunology